These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

657 related articles for article (PubMed ID: 23737229)

  • 21. [Implantable hemodynamic monitoring devices].
    Seifert M; Butter C
    Herz; 2015 Nov; 40(7):966-71. PubMed ID: 26462476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Remote monitoring: Doomed to let down or an attractive promise?
    Lucà F; Cipolletta L; Di Fusco SA; Iorio A; Pozzi A; Rao CM; Ingianni N; Benvenuto M; Madeo A; Fiscella D; Benedetto D; Francese GM; Gelsomino S; Zecchin M; Gabrielli D; Gulizia MM
    Int J Cardiol Heart Vasc; 2019 Sep; 24():100380. PubMed ID: 31193998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integration of remote monitoring of device diagnostic parameters into a multidisciplinary heart failure management program.
    Dierckx R; Houben R; Goethals M; Verstreken S; Bartunek J; Saeys R; De Proft M; Boel E; Vanderheyden M
    Int J Cardiol; 2014 Apr; 172(3):606-7. PubMed ID: 24507743
    [No Abstract]   [Full Text] [Related]  

  • 24. Fundamentals of intrathoracic impedance monitoring in heart failure.
    Wang L
    Am J Cardiol; 2007 May; 99(10A):3G-10G. PubMed ID: 17512421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implantable Cardiovascular Devices: Current and Emerging Technologies for Remote Heart Failure Monitoring.
    Gill J
    Cardiol Rev; 2023 May-Jun 01; 31(3):128-138. PubMed ID: 35349243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use and Disuse of Observational Research: The Case of Remote Monitoring in Heart Failure.
    Tavazzi L; Borer JS; Tavazzi G
    Cardiology; 2017; 137(1):14-19. PubMed ID: 27960178
    [No Abstract]   [Full Text] [Related]  

  • 27. Development of a method to risk stratify patients with heart failure for 30-day readmission using implantable device diagnostics.
    Whellan DJ; Sarkar S; Koehler J; Small RS; Boyle A; Warman EN; Abraham WT
    Am J Cardiol; 2013 Jan; 111(1):79-84. PubMed ID: 23040596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ISHNE/EHRA expert consensus on remote monitoring of cardiovascular implantable electronic devices (CIEDs).
    Dubner S; Auricchio A; Steinberg JS; Vardas P; Stone P; Brugada J; Piotrowicz R; Hayes DL; Kirchhof P; Breithardt G; Zareba W; Schuger C; Aktas MK; Chudzik M; Mittal S; Varma N
    Europace; 2012 Feb; 14(2):278-93. PubMed ID: 22232544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure.
    van Veldhuisen DJ; Braunschweig F; Conraads V; Ford I; Cowie MR; Jondeau G; Kautzner J; Aguilera RM; Lunati M; Yu CM; Gerritse B; Borggrefe M;
    Circulation; 2011 Oct; 124(16):1719-26. PubMed ID: 21931078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Remote patient monitoring in chronic heart failure.
    Palaniswamy C; Mishkin A; Aronow WS; Kalra A; Frishman WH
    Cardiol Rev; 2013; 21(3):141-50. PubMed ID: 23018667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implementation and reimbursement of remote monitoring for cardiac implantable electronic devices in Europe: a survey from the health economics committee of the European Heart Rhythm Association.
    Mairesse GH; Braunschweig F; Klersy K; Cowie MR; Leyva F
    Europace; 2015 May; 17(5):814-8. PubMed ID: 25713012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disease management: atrial fibrillation and home monitoring.
    Ricci RP
    Europace; 2013 Jun; 15 Suppl 1():i35-i39. PubMed ID: 23737228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure.
    Lindenfeld J; Feldman AM; Saxon L; Boehmer J; Carson P; Ghali JK; Anand I; Singh S; Steinberg JS; Jaski B; DeMarco T; Mann D; Yong P; Galle E; Ecklund F; Bristow M
    Circulation; 2007 Jan; 115(2):204-12. PubMed ID: 17190867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Telemedical Interventional Monitoring in Heart Failure (TIM-HF), a randomized, controlled intervention trial investigating the impact of telemedicine on mortality in ambulatory patients with heart failure: study design.
    Koehler F; Winkler S; Schieber M; Sechtem U; Stangl K; Böhm M; Boll H; Kim SS; Koehler K; Lücke S; Honold M; Heinze P; Schweizer T; Braecklein M; Kirwan BA; Gelbrich G; Anker SD;
    Eur J Heart Fail; 2010 Dec; 12(12):1354-62. PubMed ID: 21098580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioimpedance Alerts from Cardiovascular Implantable Electronic Devices: Observational Study of Diagnostic Relevance and Clinical Outcomes.
    Smeets CJ; Vranken J; Van der Auwera J; Verbrugge FH; Mullens W; Dupont M; Grieten L; De Cannière H; Lanssens D; Vandenberk T; Storms V; Thijs IM; Vandervoort PM
    J Med Internet Res; 2017 Nov; 19(11):e393. PubMed ID: 29170147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implantable devices for management of chronic heart failure: defibrillators and biventricular pacing therapy.
    Pires LA
    Curr Opin Anaesthesiol; 2006 Feb; 19(1):69-74. PubMed ID: 16547436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert.
    Small RS; Wickemeyer W; Germany R; Hoppe B; Andrulli J; Brady PA; Labeau M; Koehler J; Sarkar S; Hettrick DA; Tang WH
    J Card Fail; 2009 Aug; 15(6):475-81. PubMed ID: 19643357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study.
    Whellan DJ; Ousdigian KT; Al-Khatib SM; Pu W; Sarkar S; Porter CB; Pavri BB; O'Connor CM;
    J Am Coll Cardiol; 2010 Apr; 55(17):1803-10. PubMed ID: 20413029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wireless pulmonary artery pressure monitoring guides management to reduce decompensation in heart failure with preserved ejection fraction.
    Adamson PB; Abraham WT; Bourge RC; Costanzo MR; Hasan A; Yadav C; Henderson J; Cowart P; Stevenson LW
    Circ Heart Fail; 2014 Nov; 7(6):935-44. PubMed ID: 25286913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial.
    Conraads VM; Tavazzi L; Santini M; Oliva F; Gerritse B; Yu CM; Cowie MR
    Eur Heart J; 2011 Sep; 32(18):2266-73. PubMed ID: 21362703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.